Price: $148.64
· 1 day: -0.13% · 5 days: +4.00% · 1 month: +3.32% · YTD: +8.13%
As of 2026-10-16 07:26 UTC.
52-week range: $125.22 – $152.04 (currently at 87% of the range).
The brief
CSSMI.SW is in an uptrend, momentum firm. $150 is the level overhead; $146.33 the first support below.
6 of 6 technical checks lean bullish.
Price vs 50-day: above
Price vs 200-day: above
50d vs 200d avg: above
MACD: bullish
RSI momentum: 63
5-day tape: +4.0%
Trend
Uptrend · above 50-day & 200-day
Momentum
RSI 63.16 · neutral · MACD bullish
Trend strength
ADX 22.2 · developing
Location
+1.6% vs 50-day MA
52-week range
-2% from high · +17% from low
Volatility
ATR 1.7 · ~1.1%/day
Key levels
Level
Type
Distance
$150.0 (resistance)
round
0.91%
$151.5 (resistance)
swing zone
1.92%
$175.0 (resistance)
round
17.73%
$146.33 (support)
sma 50
-1.55%
$145.46 (support)
swing zone
-2.14%
$141.92 (support)
sma 200
-4.52%
Indicators
RSI (14)
63.16
MACD
0.2732
ADX (14)
22.2
ATR (14)
1.7
50-day average
$146.33
200-day average
$141.92
Latest CSSMI.SW news
Swiss 10-Million Cap Damage Can't Be Easily Dodged, Lombard Says — # Summary
Swiss voters will decide on June 14 whether to cap the country's population at 10 million, a measure that Lombard Odier warns would create significant economic challenges that cannot be easily mitigated. With (Bloomberg Business, 2026-06-02)
Global Indexes Hit New Records — Global equity markets reached new record highs on Thursday, with European and Asian indexes outperforming U.S. markets. Multiple European indexes including France's CAC 40, Swiss Market Index, Stoxx Europe 600, and Euro (The Wall Street Journal, 2026-02-12)
Trump's Greenland Strategy Draws From Familiar Playbook — President Trump's threats to impose tariffs on European nations have prompted a shift in diplomatic posture regarding Greenland, with European leaders now seeking meetings to discuss the territory's future. Trump announc (The Wall Street Journal, 2026-01-21)
Novartis to acquire Tourmaline Bio for $1.4 billion — Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on dev (Reuters, 2025-09-09)
European Stocks Climb With Trump and Putin Set to Meet — European stocks rose on Thursday following announcements from both the White House and Kremlin that Donald Trump and Vladimir Putin would meet for summit talks within days, raising investor hopes for a potential Ukraine (Barrons, 2025-08-07)
Switzerland facing 39% US tariff as president leaves Washington empty-handed — Swiss President Karin Keller-Sutter left Washington without securing a deal to reduce the 39% tariff on Swiss exports to the U.S., which is set to take effect Thursday. Switzerland had sought a 10% tariff rate, which U.S (Reuters, 2025-08-06)